ΒΆ anorexia nervosa
ΒΆ Definition
Anorexia nervosa (AN) is a severe eating disorder characterized by restrictive eating, intense fear of weight gain, distorted body image, and dangerously low body weight (BMI typically <17.5 kg/mΒ²). In the cPNI framework, AN represents chronic hyperactivation of the disgust system directed against the self, coupled with pathological shame responses that enforce adherence to distorted social norms, creating a self-perpetuating metabolic and immunological crisis that serves maladaptive evolutionary functions of pathogen avoidance and social conformity.
ΒΆ Picture It
Imagine your home security system has turned against you. Instead of protecting you from external threats, the alarm has been rewired to identify YOU as the contamination source. Every time you eat, sensors sound the alarm: "Intruder! Toxin detected!" The disgust systemβmeant to protect you from rotten food and pathogensβhas misidentified your own body and its needs as the enemy. Meanwhile, the "social conformity officer" (shame) is constantly checking you against an impossible blueprint of what the tribe expects, and every perceived deviation triggers punishment protocols. The house becomes a fortress against itself. To make it worse, the starvation state activates your brain's reward circuitsβlike getting a dopamine hit from denying yourself water in a desert. The more you restrict, the more the system rewards you, creating an addiction loop. Your body's fuel gauge (ghrelin) screams "EMPTY!" but the control panel (prefrontal cortex) overrides it, saying "This is how we stay safeβthis is who I AM." The identity has fused with the alarm system. You can't just "turn it off" because the person and the security protocol have become one.
ΒΆ Mechanism
Anorexia nervosa emerges from the convergence of multiple dysregulated systems:
Disgust-Behavioral Immune System Cascade:
Self-directed disgust β insula cortex hyperactivation β Behavioural Immune System (BIS) activation β IFN-gamma β (antiviral response), IL-17 β (mucosal barrier defense), IL-4 β (anti-parasitic response) β chronic low-grade systemic inflammation β body misidentified as contamination source β food avoidance behaviors reinforced
The insula cortex shows altered connectivity with anterior cingulate cortex and prefrontal cortex, disrupting normal interoception (perception of internal body states including hunger, fullness, body boundaries). fMRI studies show insula hyperactivation to food cues and body images in AN patients, correlating with disgust intensity ratings.
Shame-Social Conformity Loop:
Perceived deviation from body ideals (Gestalt rules) β shame activation β hypothalamic-pituitary-adrenal (HPA) axis dysregulation β cortisol dysregulation (often elevated morning cortisol >15 ΞΌg/dL, flattened diurnal rhythm) β increased rumination and cognitive rigidity β compulsive adherence to restrictive eating rules β temporary shame relief β cycle repeats
Shame is egodystonicβthe individual experiences "I AM bad" rather than "I HAVE a problem," causing identity fusion with the disorder. This explains treatment resistance: challenging the behavior feels like challenging core identity.
Starvation-Induced Metabolic Reinforcement:
Caloric restriction β ghrelin β (>200 pg/mL fasting, vs. normal 50-100 pg/mL) β paradoxical orexigenic signal ignored by cognitive override β leptin β (<5 ng/mL vs. normal 5-15 ng/mL) β loss of satiety signaling β hypothalamic amenorrhea (estrogen <20 pg/mL, FSH and LH suppressed) β bone density loss
Starvation triggers addiction-like reward pathways:
Food restriction β dopamine release in ventral striatum and prefrontal cortex β activation of opioid receptors (particularly mu opioid receptor) β endogenous reward β behavioral reinforcement β restriction becomes self-reinforcing despite negative metabolic consequences
Serotonergic Dysregulation:
Tryptophan depletion from malnutrition β serotonin synthesis β β altered 5-HTTLPR polymorphism expression (short allele associated with increased AN risk) β anxiety, OCD-like symptoms, mood instability β restrictive eating as control mechanism β cycle perpetuates
Neuroinflammatory Consequences:
Chronic systemic inflammation β blood-brain barrier permeability β β microglial activation in hypothalamus, hippocampus, insula cortex β neuroinflammation β altered appetite regulation circuits β further dysregulation of hunger/satiety signals
ΒΆ Clinical Significance
cPNI Framework Application:
Anorexia nervosa exemplifies evolutionary mismatchβthe disgust system evolved to protect against pathogens and contaminated food (legitimate threats in ancestral environments) but becomes pathologically redirected toward the self in modern contexts with unrealistic body ideals amplified by media. The shame system, designed to enforce tribal conformity for survival, now enforces adherence to Instagram-filtered perfection.
Diagnostic and Biomarker Considerations:
- BMI thresholds: <17.5 kg/mΒ² diagnostic; <15 kg/mΒ² severe; <13 kg/mΒ² life-threatening
- Inflammatory markers: CRP often paradoxically normal or low due to malnutrition, but IL-6 may be elevated (>10 pg/mL); ferritin often low (<15 ng/mL)
- Hormonal panel: estrogen <20 pg/mL, testosterone <10 ng/dL in females, cortisol often elevated morning values (>15 ΞΌg/dL) with flattened diurnal curve
- Metabolic markers: leptin <5 ng/mL, ghrelin >200 pg/mL fasting, albumin may be normal until severe malnutrition
- Neurotransmitter function: indirect assessment via platelet serotonin levels or urinary 5-HIAA (often low)
- Bone health: DEXA scan shows osteopenia/osteoporosis (T-score <-1.0) in 90% of chronic AN patients
Metamodel Integration:
- 5 plus 2 metamodel: AN shows dysregulation across stress axes (HPA axis), metabolic system (starvation metabolism), immune system (BIS hyperactivation), and psychological regulation (disgust/shame dominance)
- Selfish Brain theory: The brain prioritizes cognitive control (restriction) over metabolic homeostasis, creating a hierarchy where cortical override dominates hypothalamic survival signals
- selfish-immune-system: The immune system's self-protective mechanisms (disgust-mediated pathogen avoidance) become selfish, sabotaging the organism's survival in service of perceived contamination threats
Clinical Intervention Implications:
-
Address Disgust Sensitivity:
- Exposure therapy to food-related disgust triggers
- interoception training to rebuild body signal awareness
- Sensory desensitization protocols for food textures, smells
-
Externalize the Disorder (Counter Egodystonic Nature):
- Narrative therapy separating "you" from "anorexia voice"
- Identity reconstruction work: "You are not your eating disorder"
- Solution-Focused Brief Therapy to build alternative identity components
-
Immune-Metabolic Rebalancing:
- Anti-inflammatory nutrition: omega-3 fatty acids (EPA/DHA 2-3 g/day) to reduce systemic inflammation
- Gradual refeeding protocols to avoid refeeding syndrome (phosphate, magnesium, thiamine monitoring)
- zinc supplementation (30-50 mg/day) to restore taste/appetite signaling
- vitamin D repletion (often <20 ng/mL) to support immune modulation
-
Neurotransmitter Support:
- tryptophan or 5-HTP supplementation (with medical supervision) to restore serotonin synthesis once adequate caloric intake established
- Avoid SSRIs in acute starvation (limited efficacy, may worsen bone density)
-
Shame Work:
- Identify pathological Gestalt rules (internalized body ideals)
- Group therapy to challenge shared shame narratives
- Compassion-focused therapy to reduce self-directed hostility
-
Break Addiction Loop:
- Understand restriction as addiction-like process (dopamine-driven)
- Gradual exposure to feared foods with reward circuit retraining
- Mindfulness to observe urges without acting on them
Comorbidity Management:
High overlap with OCD (40-60%), anxiety disorders (50-70%), depression (50%), bulimia (cycling pattern in 30-40% of AN cases). Treat underlying disgust-shame-immune dysregulation rather than symptom-chasing individual diagnoses.
Prognostic Factors:
- Early intervention (
years illness duration) improves recovery rates from 30% to 50-60% - Mortality rate: 5-10% at 10 years, up to 20% at 20 years (highest of any psychiatric disorder)
- Causes of death: suicide (shame-driven, accounts for ~20% of mortality), cardiac complications (electrolyte imbalances, arrhythmias), multi-organ failure
ΒΆ Key Facts
- AN has highest mortality rate of any psychiatric disorder (5-20% long-term, depending on follow-up duration)
- Disgust sensitivity scores correlate with AN severity (r = 0.6-0.7 in multiple studies)
- Insula cortex shows 10-15% volume reduction in chronic AN, partially reversible with weight restoration
- Ghrelin levels in AN patients can reach >300 pg/mL (normal fasting 50-100 pg/mL), yet hunger is cognitively overridden
- Leptin typically <5 ng/mL (often <2 ng/mL in severe cases), signaling extreme energy deficit
- Hypothalamic amenorrhea occurs when body fat drops below ~17-22% in most women (estrogen <20 pg/mL)
- Cortisol awakening response often blunted or absent despite elevated morning values (>15 ΞΌg/dL)
- 90% of chronic AN patients develop osteopenia or osteoporosis (T-score <-1.0 on DEXA)
- Comorbidity: 40-60% OCD, 50-70% anxiety disorders, 50% depression, 30-40% bulimia cycling
- Treatment-resistant depression (TRD) occurs in 60-70% of AN patients, often reflecting immune-metabolic dysfunction rather than primary mood disorder
- Refeeding syndrome risk highest in first 2 weeks of nutritional rehabilitation (monitor phosphate mg/dL, magnesium <1.5 mg/dL, thiamine deficiency)
- Egodystonic nature: 70-80% of AN patients report identity fusion with disorder ("I am anorexia" vs. "I have anorexia")
ΒΆ Connections
- disgust β primary emotional driver of self-directed contamination response and food avoidance
- shame β enforces adherence to pathological body ideals through social conformity mechanisms
- Behavioural Immune System β hyperactivated against the self, misidentifying body as contamination source
- IFN-gamma β elevated as part of antiviral arm of BIS activation in AN
- IL-17 β mucosal defense cytokine upregulated, contributing to systemic inflammation
- IL-4 β anti-parasitic response activated in chronic disgust-driven states
- insula cortex β shows hyperactivation and altered connectivity, disrupting interoception and disgust processing
- ghrelin β paradoxically elevated (>200 pg/mL) during starvation, yet cognitively overridden
- leptin β severely reduced (<5 ng/mL), signaling extreme energy deficit to hypothalamus
- serotonin β depleted due to tryptophan deficiency, contributing to anxiety and OCD symptoms
- bulimia β often co-occurs in cyclical pattern with AN restriction (binge-purge subtype or alternating diagnoses)
- suicide β shame-driven self-destructive behavior accounts for ~20% of AN mortality
- addiction β restriction activates dopamine reward pathways similar to substance use disorders
- OCD β high comorbidity (40-60%) due to shared cognitive rigidity and compulsive control mechanisms
- anxiety disorders β frequently comorbid (50-70%), often preceding AN onset
- interoception β profoundly impaired in AN; patients cannot accurately perceive hunger, fullness, or body boundaries
- prefrontal cortex β hyperactivated in cognitive control of eating, overriding hypothalamic hunger signals
- hypothalamus β appetite regulation circuits suppressed; inflammation disrupts leptin/ghrelin signaling
- estrogen β levels drop to postmenopausal ranges (<20 pg/mL) with malnutrition, affecting bone density and mood
- cortisol β often elevated and dysregulated (flattened diurnal rhythm, elevated morning values >15 ΞΌg/dL)
- dopamine β released during food restriction, creating addiction-like reinforcement of starvation behaviors
- ventral striatum β reward circuit activated by restriction behaviors in AN
- anterior cingulate cortex β altered connectivity with insula disrupts error monitoring and emotional regulation
- HPA axis β dysregulated in AN due to chronic shame-stress activation and malnutrition effects
- blood-brain barrier β permeability increased by chronic inflammation, allowing immune signal entry to CNS
- neuroinflammation β microglial activation in hypothalamus and insula perpetuates appetite dysregulation
- bone metabolism β severely disrupted; osteoporosis develops in 90% of chronic AN cases
- tryptophan β depleted by malnutrition, limiting serotonin synthesis and worsening mood/anxiety
- 5-HTTLPR β serotonin transporter polymorphism (short allele) associated with increased AN risk
- mu opioid receptor β activated during food restriction, contributing to endogenous reward
- refeeding syndrome β life-threatening complication of nutritional rehabilitation (phosphate, magnesium depletion)
- egodystonic β AN is characteristically egodystonic ("I am bad"), causing identity fusion with disorder
- evolutionary mismatch β disgust and shame systems evolved for pathogen avoidance and tribal conformity, maladaptively activated by modern body ideals
- Selfish Brain β brain prioritizes cognitive control over metabolic homeostasis, overriding survival signals
- treatment-resistant depression β common in AN (60-70%), often reflecting immune-metabolic dysfunction rather than primary mood pathology
ΒΆ Module References
- Module 8